Managing Tmj Disorders

Documents to Request

• Completed TMD symptom questionnaire (DC/TMD Symptom Questionnaire)
• DC/TMD Axis II instruments (PHQ-9 for depression, GAD-7 for anxiety, JFLS for jaw function, GCPS for pain severity)
• Prior imaging (panoramic, CBCT, MRI of TMJ)
• Prior TMD treatment records (splint type, medications, physical therapy notes)
• Dental records including occlusal analysis
• Referral letters from ENT, neurology, or pain medicine if applicable
• Sleep study results (if sleep bruxism or OSA is suspected)

Step 1: DC/TMD Axis I — Clinical Examination

Standardized DC/TMD Examination Protocol

DC/TMD Axis I Diagnostic Taxonomy

Step 2: DC/TMD Axis II — Psychosocial Assessment

Required Axis II Instruments

Axis II Implications for Treatment

• Low Axis II burden (low pain disability, minimal depression/anxiety): Standard conservative treatment likely effective
• High Axis II burden (high disability, significant depression/anxiety): Multidisciplinary approach required; CBT/behavioral therapy referral; pain psychology consultation; pharmacologic management of comorbid conditions
• Axis II status is the strongest predictor of treatment outcome in chronic TMD — stronger than Axis I diagnosis

Step 3: Imaging

Imaging Selection Algorithm

Key Imaging Findings

Step 4: Treatment — Conservative Management First

Evidence-Based Treatment Hierarchy

1. Patient education: Explain diagnosis, benign natural history of most TMD, self-management strategies
2. Self-care: Soft diet, jaw rest, moist heat/ice, avoid wide opening, parafunctional habit awareness
3. Physical therapy: Manual therapy, stretching, strengthening, postural training, ultrasound, TENS
4. Pharmacotherapy: See medication table below
5. Occlusal splint therapy: See splint section below
6. Behavioral therapy/CBT: Stress management, sleep hygiene, cognitive restructuring (especially for high Axis II burden)
7. Injections: Trigger point injections, corticosteroid injections (intra-articular), botulinum toxin
8. Surgery: Arthrocentesis, arthroscopy, open joint surgery — ONLY after failure of 3–6 months of conservative management

Pharmacotherapy for TMD

Occlusal Splint Therapy

Step 5: Surgical and Interventional Management

Surgical Indications — Only After Conservative Failure

Injection Therapies

Checkpoint B: Post-Treatment Alignment (Mandatory)

1. Was the DC/TMD Axis I diagnosis established using validated examination protocol?
2. Were Axis II instruments administered and scored, with appropriate referrals for high burden?
3. Was imaging appropriate for the clinical question (not routine for all TMD patients)?
4. Was conservative management attempted for minimum 3 months before escalation?
5. Was the treatment outcome measured using the same pain scales and functional assessments as baseline?

Quality Audit

Guidelines

• DC/TMD is the standard of care for TMD diagnosis — subjective clinical impression without structured examination is insufficient
• Most TMD is self-limiting; 85% of patients improve with conservative management alone — communicate this prognosis to reduce patient anxiety
• Irreversible treatments (occlusal equilibration, orthodontics for TMD, full-mouth reconstruction) should NEVER be the initial treatment — they require confirmed diagnosis and documented failure of conservative therapy
• Soft splints (night guards from thermoplastic material) are inappropriate for TMD management and may increase nocturnal clenching
• The click associated with disc displacement with reduction is typically benign and does not require treatment unless accompanied by pain or functional limitation
• Axis II status (depression, anxiety, pain catastrophizing) is the strongest predictor of chronic TMD disability — addressing psychosocial factors is as important as addressing the physical diagnosis
• MRI is indicated for disc assessment and surgical planning, not for routine TMD screening — most TMD diagnoses are made clinically
• When multiple pain conditions coexist (TMD + migraine + fibromyalgia), treat within a multidisciplinary framework — isolated TMD treatment in the context of central sensitization has poor outcomes